November 2021 FDA Recall Drug by Denver Solutions, Llc Dba Leiters Health
D-0288-2022 - Labeling

This Class II drug recall was voluntarily initiated by Denver Solutions, Llc Dba Leiters Health on November 29, 2021 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0288-2022

Reason for Recall
Labeling: Label Mix-up: Vials labeled as moxifloxacin 1 mg/mL may actually contain moxifloxacin 5 mg/mL
Initiated
11-29-2021
Reported
12-29-2021
Quantity
1440 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Denver Solutions, LLC DBA Leiters Health
Nationwide within the United States
Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42

Batch or Lot Expiration Information

Lot# : 2130958; Expiration Date 03/31/2022